Triple
T6329910
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Title 21 of the Code of Federal Regulations |
E141952
|
entity |
| Predicate | primaryRegulatoryAgency |
P16099
|
FINISHED |
| Object | U.S. Food and Drug Administration |
E13297
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration | Statement: [Title 21 of the Code of Federal Regulations, primaryRegulatoryAgency, U.S. Food and Drug Administration]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Context triple: [Title 21 of the Code of Federal Regulations, primaryRegulatoryAgency, U.S. Food and Drug Administration]
-
A.
Food and Drug Administration
chosen
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
B.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
E.
FDA CFSAN
FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: primaryRegulatoryAgency Context triple: [Title 21 of the Code of Federal Regulations, primaryRegulatoryAgency, U.S. Food and Drug Administration]
-
A.
regulatingAgency
chosen
Indicates that one entity serves as the official authority responsible for overseeing, controlling, or enforcing rules and standards on another entity or activity.
-
B.
regulatoryType
Indicates the specific kind or category of regulatory control, rule, or oversight that applies in the given relationship.
-
C.
primaryRegulator
Indicates that one entity serves as the main controlling or governing authority over another entity or process.
-
D.
regulatoryField
Indicates that one entity operates within, is governed by, or is associated with a particular area or domain of regulation defined by another entity.
-
E.
mainRegulatoryObjective
Indicates the primary regulatory goal or purpose that guides and justifies a regulator’s actions or framework.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c008d201748190917e69c41ba3f978 |
completed | March 22, 2026, 3:20 p.m. |
| NER | Named-entity recognition | batch_69c0651334c08190a9514faa36e7812d |
completed | March 22, 2026, 9:54 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c604154a1c8190b09e74cea2a18624 |
completed | March 27, 2026, 4:14 a.m. |
| PD | Predicate disambiguation | batch_69c060e7e2d48190af9d004236466788 |
completed | March 22, 2026, 9:36 p.m. |
Created at: March 22, 2026, 4:30 p.m.